Janus Henderson Investors US’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Janus Henderson Investors US's ABBV Position: Q1 2017 in Review
Janus Henderson Investors US reduced its AbbVie (ABBV) stake by 55% in Q1 2017, selling an estimated $293M and leaving 3,880,284 shares worth $252M. The position accounts for 0.21% of the portfolio, ranked #135.
Janus Henderson Investors US first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.59B in Q4 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.
- Janus Henderson Investors US held 3,880,284 shares of AbbVie worth $252M as of Q1 2017.
- Janus Henderson Investors US sold 4,653,720 AbbVie shares in Q1 2017, an estimated $293M.
- AbbVie made up 0.21% of Janus Henderson Investors US's portfolio in Q1 2017, its #135 holding.
- Janus Henderson Investors US first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's AbbVie position peaked at $1.59B in Q4 2015.
- 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.